Q3 financials from Europe's major insurers and reinsurers will be closely scrutinised by investors, counterparties and competitors for disclosure on sovereign debt exposures and potential asset contagion.
Q3 financials from Europe's major insurers and reinsurers will be closely scrutinised by investors, counterparties and competitors for disclosure on sovereign debt exposures and potential asset contagion.